4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-048394
EVP, CFO & Treasurer acquired 30,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mason Michael EVP, CFO & Treasurer | 2022-08-31 | Grant or award | +30,000 | 168,509 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Mason Michael EVP, CFO & Treasurer | 2022-08-31 | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…